 There is an urgent need to develop vaccines against emerging diseases, including those caused by pathogens that are currently unknown to cause human disease, termed 'disease X '. Here, Zika<GPE> virus infection is considered as an example of disease X. The speed of Zika<GPE> vaccine development provides optimism for our ability to prepare vaccines against unknown pathogens.